Researchers sought to identify and characterize stroke in COVID-19 in a single healthcare system in New York.
The correct diagnosis of paraproteinemic neuropathy was missed in almost 1 in 5 patients in this study cohort.
Researchers sought to identify health care system factors that contribute to missed or delayed diagnosis of dementia by primary care providers.
In an effort to aid real-time epidemiology efforts, researchers have unveiled a mobile application called the COVID Symptom Tracker.
A panel prepared a comprehensive set of practice implications for clinicians caring for adults with acute ischemic stroke with confirmed or suspected of having COVID-19.
Researchers explored alterations in PREEMPT protocol and the explanations for them using an anonymous questionnaire to headache clinicians.
Biota Biosciences announced the voluntary recall of CBD Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables due to the products being marketed without the approval of the FDA.
A study finds that a majority of patients with Parkinson disease report difficulties in achieving early detection of their disease.
Precision medicine offers a promising therapeutic strategy for patients with Parkinson disease, allowing for tailored treatments which reflect the unique pathophysiology in each patient.
In light of the changes inflicted by the COVID-19 pandemic, the researchers wished to explore the effects of the pandemic on stroke management during the first month of Italy’s lockdown.